Creative Biolabs Provides IVD Kit Development Based on ELISA and Immunohistochemistry

New York, April 25 Backed by years of experience, Creative Biolabs is capable of providing the most sensitive and reproducible in vitro diagnostic (IVD) kit or assay development services based on ELISA and immunohistochemistry for global clients.

Through years of validation, in vitro diagnostics (IVD) proves to practical and effective in detection and diagnosis of varieties of diseases, to mitigate, cure, and prevent diseases and their complications. Therefore, IVD kit development products differentiated from high-performance formulations provide a quicker path to commercialization for an ELISA/EIA or immunohistochemistry assay.

Enzyme Linked Immune Sorbent Assay (ELISA) is considered as one of the most widely used techniques for protein detection due to its high sensitivity, high specificity, excellent accuracy, and practicality. Various methods and strategies of ELISA Kits based on different signal-transducer principles have been developed in Creative Biolabs including but not limited to:

  • Colorimetric Immunoassay (CIA) Based Kits Development
  • Chemiluminescent Immunoassays (CLIA) Based Kits Development
  • Electrochemiluminescence Immunoassay (ECLIA) Based Kits Development
  • Time Resolved Fluorescence Immunoassay (TRFIA) Based Kits Development
  • Enzyme-linked Immunosorbent Spot (ELISpot) Based Kits Development
  • Immuno-PCR Based Kits Development
  • Protein Microarray Based Kits Development

As an extremely powerful tool in the diagnostic and research laboratories, immunohistochemistry (IHC) utilizes monoclonal and polyclonal antibodies for the detection of specific antigens in tissue sections, which plays an essential role in pathology, especially in the subspecialties of tumor pathology, neuropathology, and hematopathology.

In addition to machine-operated IHC staining services, Creative Biolabs is also skilled at manufacturing IHC-based kits for IVD study. The routinely experimental flow of IHC includes processes as follows:

  • Sample preparation
  • Immobilization
  • Tissue sectioning
  • Paraffin embedding
  • Blocking
  • Antigen retrieval
  • Detection
  • Counterstain
  • Mounting media


Using novel techniques and formulations, the technical team at Creative Biolabs can overcome obstacles in development and build robust and reproducible assays for our clients. Cell line slides and tissues from different organs can be used if customers do not have. And optimization of experimental conditions is also available for the primary antibody, like concentrations, incubation times, and interpretation of the staining results. More information can be reached at



Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, scientists in Creative Biolabs are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Creative Biolabs is able to undertake the entire discovery pipeline and also pleased to offer specific service based on clients’ requirements.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States